MAIA Biotechnology, Inc. (MAIA) vs OS Therapies Incorporated (OSTX)

MAIA Biotechnology, Inc. and OS Therapies Incorporated are both Biotechnology companies. MAIA Biotechnology, Inc. and OS Therapies Incorporated are of similar size ($77.7M and $76.0M). Across the 7 metrics below, MAIA Biotechnology, Inc. leads on 4 and OS Therapies Incorporated on 3.

Valuation

Metric MAIA OSTX Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 3.53 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m n/m 10.73
Earnings yield (52.48%) (65.66%) (28.84%)
Free cash flow yield (30.94%) (25.43%) (23.03%)

Profitability

Metric MAIA OSTX Biotechnology median
Gross margin — — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (218.68%) 1,129.52% (57.72%)
Return on assets (136.67%) (389.65%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric MAIA OSTX Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 33.33% 23.32% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric MAIA OSTX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.51 0.18 4.73
Net debt to EBITDA 0.36 0.01 0.96

Dividend

Metric MAIA OSTX Biotechnology median
Dividend yield — — 2.10%
Payout ratio — — 0.00

Size

Metric MAIA OSTX Biotechnology median
Market cap 76.04m 77.70m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack